Mirafuentes, Analyn J.
HRN: 22-34-23 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/20/2022
CEFUROXIME 500MG (TAB)
12/20/2022
12/27/2022
ORAL
500mg
BID
UTI
Waiting Final Action
Indication: Prophylaxis Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes